_id
690dad23ccc777a4e85d09e6
Ticker
ALFRY
Name
Alfresa Holdings Corp Tokyo ADR
Exchange
OTCGREY
Address
Ote Center Building, Tokyo, Japan, 100-0004
Country
USA
Sector
Healthcare
Industry
Medical Distribution
Currency
USD
Website
https://www.alfresa.com
Description
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.
Last Close
15.14
Volume
-
Current Price
15.14
Change
0
Last Updated
2026-01-22T04:12:09.499Z
Image
-
Ipo Date
-
Market Cap
2751220224
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-03-31
Revenue
678697000000
Cost Of Revenue
626620000000
Gross Profit
52077000000
Operating Expenses
670180000000
Operating Income
8517000000
Interest Expense
65000000
Pretax Income
12886000000
Net Income
8687000000
Eps
46.48714388055723
Dividends Per Share
-
Shares Outstanding
181718647
Income Tax Expense
-
EBITDA
-
Operating Margin
1.2549046187031916
Total Other Income Expense Net
-
Cash
213756000000
Short Term Investments
-
Receivables
646113000000
Inventories
156377000000
Total Current Assets
1121233000000
Property Plant Equipment
181601000000
Total Assets
1447625000000
Payables
855328000000
Short Term Debt
-
Long Term Debt
30000000000
Total Liabilities
967767000000
Equity
479599000000
Bs_currency_symbol
JPY
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
JPY
PE
17.6047
PB
0.005899083769273915
ROE
1.811304860935907
ROA
0.6000863483291599
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
37
Deep Value Investing Score
6
Defensive Investing Score
4.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1.5
Momentum Investing Score
3.5
Net Net Investing Score
8
Quality Investing Score
3
Value Investing Score
6
Quarters > 0 > quarter
2024-03-31
Quarters > 0 > income Statement > revenue
678697000000
Quarters > 0 > income Statement > cost Of Revenue
626620000000
Quarters > 0 > income Statement > gross Profit
52077000000
Quarters > 0 > income Statement > operating Expenses
670180000000
Quarters > 0 > income Statement > operating Income
8517000000
Quarters > 0 > income Statement > interest Expense
65000000
Quarters > 0 > income Statement > pretax Income
12886000000
Quarters > 0 > income Statement > net Income
8687000000
Quarters > 0 > income Statement > eps
46.48714388055723
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
186868869
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
1.2549046187031916
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
JPY
Quarters > 0 > balance Sheet > cash
213756000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
646113000000
Quarters > 0 > balance Sheet > inventories
156377000000
Quarters > 0 > balance Sheet > total Current Assets
1121233000000
Quarters > 0 > balance Sheet > property Plant Equipment
181601000000
Quarters > 0 > balance Sheet > total Assets
1447625000000
Quarters > 0 > balance Sheet > payables
855328000000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
30000000000
Quarters > 0 > balance Sheet > total Liabilities
967767000000
Quarters > 0 > balance Sheet > equity
479599000000
Quarters > 0 > balance Sheet > currency_symbol
JPY
Quarters > 0 > cash Flow > net Income
8687000000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
JPY
Quarters > 0 > ratios > PE
46.48714388055723
Quarters > 0 > ratios > PB
0.005899083769273915
Quarters > 0 > ratios > ROE
1.811304860935907
Quarters > 0 > ratios > ROA
0.6000863483291599
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2023-12-31
Quarters > 1 > income Statement > revenue
751947000000
Quarters > 1 > income Statement > cost Of Revenue
696878000000
Quarters > 1 > income Statement > gross Profit
55068000000
Quarters > 1 > income Statement > operating Expenses
738000000000
Quarters > 1 > income Statement > operating Income
13946000000
Quarters > 1 > income Statement > interest Expense
32000000
Quarters > 1 > income Statement > pretax Income
13553000000
Quarters > 1 > income Statement > net Income
9021000000
Quarters > 1 > income Statement > eps
48.27426822408878
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
186869741
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
1.8546519901003662
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
JPY
Quarters > 1 > balance Sheet > cash
200816000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
700892000000
Quarters > 1 > balance Sheet > inventories
175500000000
Quarters > 1 > balance Sheet > total Current Assets
1184803000000
Quarters > 1 > balance Sheet > property Plant Equipment
181908000000
Quarters > 1 > balance Sheet > total Assets
1500114000000
Quarters > 1 > balance Sheet > payables
936005000000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
30000000000
Quarters > 1 > balance Sheet > total Liabilities
1035772000000
Quarters > 1 > balance Sheet > equity
464040000000
Quarters > 1 > balance Sheet > currency_symbol
JPY
Quarters > 1 > cash Flow > net Income
9021000000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
JPY
Quarters > 1 > ratios > PE
48.27426822408878
Quarters > 1 > ratios > PB
0.006096905177872597
Quarters > 1 > ratios > ROE
1.9440134471166277
Quarters > 1 > ratios > ROA
0.6013542970734224
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
37
Quarters > 2 > quarter
2023-09-30
Quarters > 2 > income Statement > revenue
718800000000
Quarters > 2 > income Statement > cost Of Revenue
667389000000
Quarters > 2 > income Statement > gross Profit
51411000000
Quarters > 2 > income Statement > operating Expenses
708638000000
Quarters > 2 > income Statement > operating Income
10162000000
Quarters > 2 > income Statement > interest Expense
20000000
Quarters > 2 > income Statement > pretax Income
10976000000
Quarters > 2 > income Statement > net Income
7801000000
Quarters > 2 > income Statement > eps
41.65544939328259
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
187274417
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
1.4137451307735114
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
JPY
Quarters > 2 > balance Sheet > cash
186165000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
668591000000
Quarters > 2 > balance Sheet > inventories
152924000000
Quarters > 2 > balance Sheet > total Current Assets
1108111000000
Quarters > 2 > balance Sheet > property Plant Equipment
178855000000
Quarters > 2 > balance Sheet > total Assets
1426216000000
Quarters > 2 > balance Sheet > payables
872276000000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
960664000000
Quarters > 2 > balance Sheet > equity
465269000000
Quarters > 2 > balance Sheet > currency_symbol
JPY
Quarters > 2 > cash Flow > net Income
7801000000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
JPY
Quarters > 2 > ratios > PE
41.65544939328259
Quarters > 2 > ratios > PB
0.006093968593179429
Quarters > 2 > ratios > ROE
1.6766644672221875
Quarters > 2 > ratios > ROA
0.546971847181633
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2022-06-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
1410000000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
616379000000
Quarters > 3 > balance Sheet > inventories
146674000000
Quarters > 3 > balance Sheet > total Current Assets
1026422000000
Quarters > 3 > balance Sheet > property Plant Equipment
164578000000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
780006000000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
823529000000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
2124000000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
2961051000000
Annuals > 0 > income Statement > cost Of Revenue
2747123000000
Annuals > 0 > income Statement > gross Profit
213927000000
Annuals > 0 > income Statement > operating Expenses
2922969000000
Annuals > 0 > income Statement > operating Income
38081000000
Annuals > 0 > income Statement > interest Expense
279000000
Annuals > 0 > income Statement > pretax Income
39359000000
Annuals > 0 > income Statement > net Income
27389000000
Annuals > 0 > income Statement > eps
150.663951704714
Annuals > 0 > income Statement > dividends Per Share
12550000000
Annuals > 0 > income Statement > shares Outstanding
181788674
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
1.2860636307851503
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
JPY
Annuals > 0 > balance Sheet > cash
177085000000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
645778000000
Annuals > 0 > balance Sheet > inventories
167669000000
Annuals > 0 > balance Sheet > total Current Assets
1094496000000
Annuals > 0 > balance Sheet > property Plant Equipment
192436000000
Annuals > 0 > balance Sheet > total Assets
1439885000000
Annuals > 0 > balance Sheet > payables
834925000000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
30000000000
Annuals > 0 > balance Sheet > total Liabilities
957639000000
Annuals > 0 > balance Sheet > equity
481787000000
Annuals > 0 > balance Sheet > currency_symbol
JPY
Annuals > 0 > cash Flow > net Income
27389000000
Annuals > 0 > cash Flow > depreciation
14923000000
Annuals > 0 > cash Flow > change In Working Capital
-35622000000
Annuals > 0 > cash Flow > cash From Operations
5639000000
Annuals > 0 > cash Flow > capital Expenditures
20128000000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-42714000000
Annuals > 0 > cash Flow > currency_symbol
JPY
Annuals > 0 > ratios > PE
150.663951704714
Annuals > 0 > ratios > PB
0.005712650039042149
Annuals > 0 > ratios > ROE
5.684877342061948
Annuals > 0 > ratios > ROA
1.9021657979630318
Annuals > 0 > ratios > FCF
-14489000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.004893195017579907
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
2858500000000
Annuals > 1 > income Statement > cost Of Revenue
2652128000000
Annuals > 1 > income Statement > gross Profit
206371000000
Annuals > 1 > income Statement > operating Expenses
2820038000000
Annuals > 1 > income Statement > operating Income
38461000000
Annuals > 1 > income Statement > interest Expense
132000000
Annuals > 1 > income Statement > pretax Income
43795000000
Annuals > 1 > income Statement > net Income
29558000000
Annuals > 1 > income Statement > eps
158.17508907810642
Annuals > 1 > income Statement > dividends Per Share
12245000000
Annuals > 1 > income Statement > shares Outstanding
186868869
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
1.3454958894525102
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
JPY
Annuals > 1 > balance Sheet > cash
213756000000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
646113000000
Annuals > 1 > balance Sheet > inventories
156377000000
Annuals > 1 > balance Sheet > total Current Assets
1121233000000
Annuals > 1 > balance Sheet > property Plant Equipment
181601000000
Annuals > 1 > balance Sheet > total Assets
1447625000000
Annuals > 1 > balance Sheet > payables
855328000000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
30000000000
Annuals > 1 > balance Sheet > total Liabilities
967767000000
Annuals > 1 > balance Sheet > equity
479599000000
Annuals > 1 > balance Sheet > currency_symbol
JPY
Annuals > 1 > cash Flow > net Income
29558000000
Annuals > 1 > cash Flow > depreciation
13514000000
Annuals > 1 > cash Flow > change In Working Capital
43793000000
Annuals > 1 > cash Flow > cash From Operations
86379000000
Annuals > 1 > cash Flow > capital Expenditures
15328000000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
52502000000
Annuals > 1 > cash Flow > currency_symbol
JPY
Annuals > 1 > ratios > PE
158.17508907810642
Annuals > 1 > ratios > PB
0.005899083769273915
Annuals > 1 > ratios > ROE
6.16306539421475
Annuals > 1 > ratios > ROA
2.041827130645022
Annuals > 1 > ratios > FCF
71051000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.024856043379394788
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
2696069000000
Annuals > 2 > income Statement > cost Of Revenue
2503983000000
Annuals > 2 > income Statement > gross Profit
192085000000
Annuals > 2 > income Statement > operating Expenses
2665920000000
Annuals > 2 > income Statement > operating Income
30148000000
Annuals > 2 > income Statement > interest Expense
64000000
Annuals > 2 > income Statement > pretax Income
38591000000
Annuals > 2 > income Statement > net Income
25786000000
Annuals > 2 > income Statement > eps
127.4207017873291
Annuals > 2 > income Statement > dividends Per Share
11138000000
Annuals > 2 > income Statement > shares Outstanding
202369000
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
1.1182206390118354
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
JPY
Annuals > 2 > balance Sheet > cash
160122000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
623653000000
Annuals > 2 > balance Sheet > inventories
152790000000
Annuals > 2 > balance Sheet > total Current Assets
1034527000000
Annuals > 2 > balance Sheet > property Plant Equipment
176821000000
Annuals > 2 > balance Sheet > total Assets
1339852000000
Annuals > 2 > balance Sheet > payables
780343000000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
851518000000
Annuals > 2 > balance Sheet > equity
488090000000
Annuals > 2 > balance Sheet > currency_symbol
JPY
Annuals > 2 > cash Flow > net Income
25786000000
Annuals > 2 > cash Flow > depreciation
13302000000
Annuals > 2 > cash Flow > change In Working Capital
-8595000000
Annuals > 2 > cash Flow > cash From Operations
13086000000
Annuals > 2 > cash Flow > capital Expenditures
25465000000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-20332000000
Annuals > 2 > cash Flow > currency_symbol
JPY
Annuals > 2 > ratios > PE
127.4207017873291
Annuals > 2 > ratios > PB
0.006277257595935176
Annuals > 2 > ratios > ROE
5.283042061914811
Annuals > 2 > ratios > ROA
1.9245409194448342
Annuals > 2 > ratios > FCF
-12379000000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
-0.004591499698264399
Annuals > 2 > health Score
32
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
2585643000000
Annuals > 3 > income Statement > cost Of Revenue
2398174000000
Annuals > 3 > income Statement > gross Profit
187468000000
Annuals > 3 > income Statement > operating Expenses
2556551000000
Annuals > 3 > income Statement > operating Income
29091000000
Annuals > 3 > income Statement > interest Expense
73000000
Annuals > 3 > income Statement > pretax Income
48180000000
Annuals > 3 > income Statement > net Income
32182000000
Annuals > 3 > income Statement > eps
159.02534845375718
Annuals > 3 > income Statement > dividends Per Share
11430000000
Annuals > 3 > income Statement > shares Outstanding
202370253
Annuals > 3 > income Statement > income Tax Expense
15977000000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
1.1250973162188282
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
180436000000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
602488000000
Annuals > 3 > balance Sheet > inventories
146889000000
Annuals > 3 > balance Sheet > total Current Assets
1016471000000
Annuals > 3 > balance Sheet > property Plant Equipment
162758000000
Annuals > 3 > balance Sheet > total Assets
1303991000000
Annuals > 3 > balance Sheet > payables
755250000000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
832159000000
Annuals > 3 > balance Sheet > equity
471591000000
Annuals > 3 > balance Sheet > currency_symbol
JPY
Annuals > 3 > cash Flow > net Income
13595000000
Annuals > 3 > cash Flow > depreciation
12824000000
Annuals > 3 > cash Flow > change In Working Capital
-4860000000
Annuals > 3 > cash Flow > cash From Operations
36546000000
Annuals > 3 > cash Flow > capital Expenditures
15002000000
Annuals > 3 > cash Flow > cash From Investing
2304000000
Annuals > 3 > cash Flow > cash From Financing
-29151000000
Annuals > 3 > cash Flow > net Change In Cash
10047000000
Annuals > 3 > cash Flow > currency_symbol
JPY
Annuals > 3 > ratios > PE
159.02534845375718
Annuals > 3 > ratios > PB
0.006496912855461618
Annuals > 3 > ratios > ROE
6.824133624263398
Annuals > 3 > ratios > ROA
2.467961818754884
Annuals > 3 > ratios > FCF
21544000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.008332163411576927
Annuals > 3 > health Score
33
Valuation > metrics > PE
46.48714388055723
Valuation > metrics > PB
0.005899083769273915
Valuation > final Score
44.21542734333133
Valuation > verdict
6.7% Undervalued
Profitability > metrics > ROE
1.811304860935907
Profitability > metrics > ROA
0.7747720589743613
Profitability > metrics > Net Margin
0.012799526150844927
Profitability > final Score
8
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.017867009731046
Risk > metrics > Interest Coverage
131.03076923076924
Risk > final Score
58
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.3108807381495753
Liquidity > metrics > Quick Ratio
1.1280537992442665
Liquidity > final Score
83
Liquidity > verdict
Great
Prev Valuations > 0
42.070878131093465
Prev Valuations > 1
50.01346072806089
Prev Valuations > 2
50
Prev Profitabilities > 0
8
Prev Profitabilities > 1
7
Prev Profitabilities > 2
50
Prev Risks > 0
58
Prev Risks > 1
58
Prev Risks > 2
50
Prev Liquidities > 0
82
Prev Liquidities > 1
82
Prev Liquidities > 2
83
Updated At
2026-01-22T04:12:10.316Z
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AARS Pharma stock rises on Japan nod for neffy (SPRY:NASDAQ) Seeking Alpha
Read more →(Last Updated 2024-03-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Alfresa Holdings Corp Tokyo ADR
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-03-31)
(Last Updated 2024-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.